OmniVision's income, revenue jump in billion-dollar year

OmniVision ($OVTI) pulled in $336.2 million in revenue in its fiscal fourth quarter, a 53% jump over the same period last year, and its net income more than tripled to $8.9 million. For the full fiscal year, the company grossed $1.4 billion in sales, a record haul that nearly doubled 2012 revenue. Results

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.